Article Details
Retrieved on: 2024-04-23 17:39:45
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses RootPath's synthetic biology advances in cancer research by creating synthetic tumor-infiltrating lymphocytes (TILs), which enhances T cell cancer immunotherapy, offering potential for more effective and affordable cancer treatments.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here